Pertinence des actes d`angioplasties chez des patients coronariens

Comité de Coordination de l’Evaluation Clinique et de la Qualité en Aquitaine
Hôpital Xavier Arnozan - 33604 Pessac Cedex - Tél : [phone] - Fax : [phone]
www.ccecqa.asso.fr
!
!
!
!
!
Pertinence des actes d’angioplasties
chez des patients coronariens
stables
Programme de
développement professionnel continu
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
Rédacteur : Emilie Lesaine
Relecteurs : Florence Saillour-Glenisson, Catherine Pourin, Jean-Luc Quenon
Date : novembre 2013
! !

CCECQA
! 2
Résumé!
!
"#!$%&'%())#!*#!*+,#-&$$#)#./!$%&0#112&..#-!3&./2.4!567"8!(!$&4%!&9:#3/20!*;()+-2&%#%!-;2.*23(/2&.!*#1!
(3/#1! *;(.'2&$-(1/2#! $&4%! -#1! $(/2#./1! 3&%&.(%2#.1! 1/(9-#1! 5<&%1! 4%'#.3#8=! >-! 1?(*%#11#! (4@! )+*#32.1!
3(%*2&-&'4#1!(.'2&$-(1/232#.1!#.'('+1!*(.1!-#!%#'21/%#!(A42/(2.!*#!3(%*2&-&'2#!2./#%,#./2&..#--#!5B">CB8=!>-!
$#%)#/!*#!,(-2*#%!-#!67"!*#!3#1!$%&0#112&..#-1!*#!1(./+=!
>-!1?('2/!*?4.!$%&'%())#!(..4#-!A42!3&)$&%/#!/%&21!+/($#1!D!!
E 4.#!(.(-F1#!*;2.*23(/#4%1!*#!$%(/2A4#!3-2.2A4#!%#34#2--21!$(%!-#!%#'21/%#!*#!$%(/2A4#1!B">CB!G!
E 4.#! 0&%)(/2&.! $%+1#./2#--#! *?4.#! :&4%.+#! 14%! H!-;2.*23(/2&.! *#1! (3/#1! *;(.'2&$-(1/2#! 3<#I! -#1!
$(/2#./1!3&%&.(%2#.1!1/(9-#1!J!G!
E 4.#!+/($#!*?+,(-4(/2&.!*#!-?()+-2&%(/2&.!*#1!$%(/2A4#1K!(,#3!142,2!*#1!2.*23(/#4%1!L!M!(.=!
N#1!$%&0#112&..#-1!A42!1?#.'('#./!$#4,#./!O/%#!-29+%(4@!&4!1(-(%2+1K!)(21!*&2,#./!/%(,(2--#%!*(.1!4.!3#./%#!
*#!3(%*2&-&'2#!2./#%,#./2&..#--#!#.!BA42/(2.#=!
!
Définitions!
!
N(!3(%*2&-&'2#!2./#%,#./2&..#--#!D!
N(!3&%&.(%&'%($<2#!#1/!4.#!/#3<.2A4#!*;2)('#%2#!)+*23(-#!4/2-21+#!#.!3(%*2&-&'2#!$&4%!,214(-21#%!-#1!(%/P%#1!
3&%&.(2%#1=! Q--#!$#4/! O/%#! 3&)$-+/+#! $(% 4.#! (.'2&$-(1/2#! 3&%&.(2%#! #.! 3(1! *#! 1/+.&1#! *;4.#! (%/P%#=
N;(.'2&$-(1/2#!3&%&.(2%#!3&.121/#!L!/%(2/#%!4.#!(%/P%#!3&%&.(2%#!%+/%+32#!#.!-(!*2-(/(./!(4!)&F#.!*;4.#!1&.*#!
)4.2#! *;4.! 9(--&.! '&.0-(9-#! L! 1&.! #@/%+)2/+= 6(.1! -(! /%P1! '%(.*#! )(:&%2/+! *#1! 3(1! -;(.'2&$-(1/2#! (4!
9(--&..#/!#1/!3&)$-+/+#!$(%!-(!)21#!#.!$-(3#!*;4.!1/#./K!$#/2/#!$%&/<P1#!)+/(--2A4#!#.!0&%)#!*#!%#11&%/!A42!
#1/!1#%/2#!14%!-#!9(--&..#/=!
R.#!(.'2&$-(1/2#!3&%&.(2%#!$#4/EO/%#!%+(-21+#!#.!4%'#.3#!-&%1!*;4.!1F.*%&)#!3&%&.(%2#.!(2'4S!52.0(%3/41!*4!
)F&3(%*#K!(.'&%!2.1/(9-#8!&4!#.!$%&'%())+!3<#I!-#1!$(/2#./1!1/(9-#1!$%+1#./(./!*#1!*&4-#4%1!*;(.'2.#!*#!
$&2/%2.#!.&.!3&./%T-+#1!$(%!-#1!)+*23()#./1!&4!(,#3!*#1!3%2/P%#1!*#!'%(,2/+!-&%1!*#1!#@()#.1!.&.!2.,(1201=!
!
N#!%#'21/%#!*#!$%(/2A4#1!B">CB!D!
R.! %#'21/%#! *#! $%(/2A4#1! #1/! 4.#! 9(1#! *#! *&..+#1! 3&.1/2/4+#! *#! *&..+#1! 1/(.*(%*21+#1! 2114#1! *#1!
$%(/2A4#1!$%&0#112&..#--#1!L!$%&$&1!*?4.!/<P)#!1$+3202A4#=!
N#! %#'21/%#! B">CB! 1;2./+%#11#! (4@!(3/#1! *#! 3&%&.(%&'%($<2#! #/! *?(.'2&$-(1/2#! 3&%&.(2%#!%+(-21+1! *(.1! -#1!
3#./%#1!*#!3(%*2&-&'2#!2./#%,#./2&..#--#!5">8=!"#!%#'21/%#K!$2-&/+!$(%!-;BCU!BA42/(2.#!#/!)21!#.!$-(3#!$(%!-#!
""Q"VBK!3&.1/2/4#!4.!&4/2-!*#!,2'2-(.3#!#/!*?+,(-4(/2&.!*#1!$%(/2A4#1!*(.1!-#1!3#./%#1!*#!">=!N?()+-2&%(/2&.!
3<#%3<#!L!$&%/#%!/(./!14%!-(!A4(-2/+!*#!-(!$%21#!#.!3<(%'#!*#1!$(/2#./1!A4#!14%!-(!)(2/%21#!*#1!*+$#.1#1!!#/!-(!
$#%/2.#.3#!*#1!(3/#1!$%#13%2/1!5M8=!>-!$#%)#/!*?+,(-4#%!-;2)$(3/!*4!'#1/#!*#!%#,(134-(%21(/2&.!#/!*#!3&..(W/%#!
-?+/(/!*#!1(./+!*#1!$(/2#./1!:41A4?L!4.!(.!($%P1!-?+,+.#)#./!(2'4!'%X3#!(4!142,2!$%+,4=!
N#! %#'21/%#! *#! $%(/2A4#1! B">CB!(! &9/#.4! -;(4/&%21(/2&.! 6CEYZMME[\]! *#! -(! "&))2112&.! .(/2&.(-#! *#!
-?2.0&%)(/2A4#!#/!*#1!-29#%/+1!5"^>N8!-#!Y_!&3/&9%#!YZMM!#/!#1/!2.*+$#.*(./!*#!/&4/#!2.0-4#.3#!+3&.&)2A4#K!
02.(.32P%#! &4! 3&))#%32(-#! $&4%! 1(!3&.3#$/2&.K! 1(!)21#! #.! `4,%#K! -#! 142,2! *#1!%+14-/(/1! (2.12! A4#! $&4%!
-;#@$-&2/(/2&.! #/! -(! 3&))4.23(/2&.! *#! 3#4@E32=!B11&32+! L! 4.#! *+)(%3<#! *;()+-2&%(/2&.! *#! -(! A4(-2/+K! -#!
%#'21/%#!B">CB!%#1$#3/#!-#1!3&.*2/2&.1!.+3#11(2%#1!$&4%!O/%#!%#3&..4!3&))#!4.#!*+)(%3<#!*#!67"!5Y8=!
!
>.*23(/#4%!*#!$%(/2A4#!3-2.2A4#!D!
R.!2.*23(/#4%!#1/!4.!&4/2-!*#!)#14%#!*?4.!+/(/!*#!1(./+K!*?4.#!$%(/2A4#K!*;4.!$%&3#1141!&4!*#!-(!14%,#.4#!
*?4.!+,+.#)#./!A42!$#%)#/!*?#1/2)#%!*#!)(.2P%#!,(-2*#!#/!02(9-#!-(!A4(-2/+!*#1!1&2.1!#/!1#1!,(%2(/2&.1!*(.1!
-#!/#)$1=!R.#!3&)$(%(21&.!#1/!.+3#11(2%#!$&4%!:4'#%!*#!-?+,&-4/2&.!#.!-2#.!(,#3!-#1!$-(.1!*?()+-2&%(/2&.=!
"#%/(2.1!2.*23(/#4%1!&./! ,&3(/2&.!L! O/%#!'+.+%(-21+1K!1&41! 3&4,#%/!*?4.#!)+/<&*&-&'2#! (*($/+#K! $&4%!*#1!
3&)$(%(21&.1!*(.1!-?#1$(3#=!>-1!$#4,#./!$&%/#%!3-(112A4#)#./!14%!*#1!*&..+#1!3-2.2A4#1K!-?&%'(.21(/2&.!*#1!
1&2.1!#/!-(!1(/210(3/2&.!*#1!$(/2#./1=!7#4/!(4112!O/%#!$%21#!#.!3&)$/#!1#-&.!-#1!&9:#3/201K!-(!1(/210(3/2&.!*#1!
$%&0#112&..#-1!*#!1(./+=!
N#1! 2.*23(/#4%1! *#! $%(/2A4#! 3-2.2A4#! $#%)#//#./! *;&9:#3/2,#%! -#! .2,#(4! *#! A4(-2/+! *#1! $%(/2A4#1!
$%&0#112&..#--#1=!

CCECQA
! 3
!
Choix!du!thème!
!
N#! .&)9%#! *?(.'2&$-(1/2#1! 3&%&.(2%#1! %+(-21+#1! #1/! #.! 3&.1/(./#! (4')#./(/2&.! #/! -(! )(:#4%#! $(%/2#! -?#1/!
$&4%!-(!$%21#!#.!3<(%'#!*#!-?(.'&%!3<%&.2A4#!1/(9-#=!N?2)$-(./(/2&.!*#!1/#./1!*(.1!-#1!3&%&.(2%#1!-&%1!*;4.#!
(.'2&$-(1/2#!.;(!$&4%/(./!$(1!0(2/!$%#4,#!*#!1&.!#0023(32/+!$(%!%($$&%/!(4!/%(2/#)#./!)+*23(-!1#4-!3<#I!-#1!
$(/2#./1! 3&%&.(%2#.1! 1/(9-#1K! #.! /#%)#1! *#! %+*43/2&.! *#! -(! )&%/(-2/+K! *;2.0(%3/41! *4! )F&3(%*#! &4!
*;+,+.#)#./1!3(%*2&,(134-(2%#1!5\K[8=!"#/!(3/#!#1/!3#$#.*(./!92#.!$-41!3&a/#4@!#/!3&)$&%/#!+'(-#)#./!*#1!
%21A4#1=! U#-&.! *#1! +/4*#1!()+%23(2.#1!5bcd8K! !MZ! L! Mb!e! *#1! (.'2&$-(1/2#1! $%(/2A4+#1! 3<#I! *#1! $(/2#./1!
(.'2.#4@! 1/(9-#1! 1&./! 3&.12*+%+#1! 3&))#! .&.! :41/202+#1!1#-&.! -#1! 3%2/P%#1! *#!
-;B""fgU"B>gUhUgBBhUgBiBgBU^"M!+/(9-21!#.!YZZj!5j8=!!
N#1!%#3&))(.*(/2&.1!3&.:&2./#1!*#!-;Q4%&$#(.!U&32#/F!&0!"(%*2&-&'FK!*#!-;Q4%&$#(.!B11&32(/2&.!0&%!"(%*2&E
h<&%(323! U4%'#%F!#/! *#!-;B""fgBiBgU"B>Y!$%+321#./! A4#! -;(.'2&$-(1/2#! 3<#I! -#1! $(/2#./1! (,#3! 4.#! )(-(*2#!
3&%&.(2%#! 1/(9-#K! .+3#112/#! 4.#! *&34)#./(/2&.! $%+(-(9-#! $(%! *#1! tests$ d'ischémie$ non$ invasifs!5+$%#4,#!
*;#00&%/K! 132./2'%($<2#K! +3<&'%($<2#! *#! 1/%#118!5MZKMM8=! "#$#.*(./K! (4@! Q/(/1ER.21K! 1#4-#)#./! [b! e! *#1!
3&%&.(%2#.1!1/(9-#1!&./!*#1!/#1/1!*;213<+)2#!*(.1!-#1!/%&21!)&21!$%+3+*(./!4.#!(.'2&$-(1/2#!5MY8=!N(!)#14%#!
*#!-(!%+1#%,#!3&%&.(2%#!5ffC!D!f%(3/2&.(-!f-&k!C#1#%,#8!#1/!4.#!/#3<.2A4#!*#!%+0+%#.3#!$&4%!#1/2)#%!12!4.#!
-+12&.!3&%&.(2%#!#1/!L!-;&%2'2.#!*;4.#!213<+)2#!)F&3(%*2A4#=!"<#I!-#1!$(/2#./1!(*%#11+1!*;#)9-+#!#.!1(--#!*#!
3(/<+/+%21)#! 1(.1! (434.#! +$%#4,#! 0&.3/2&..#--#! $%+(-(9-#K! -;4/2-21(/2&.! *#!-(! ffC!#1/! %#3&))(.*+#! #/! (!
*+)&./%+!1&.!2./+%O/!5M\8=!!
h&4/#0&21K! (4:&4%*;<42K! -(! *+3212&.! *#!%#3&4%2%! L! -;(.'2&$-(1/2#! #1/! #.3&%#!'+.+%(-#)#./! $%21#! 142,(./!
-;($$(%#.3#!*#1!-+12&.1!L!-(!3&%&.(%&'%($<2#K!1(.1!4/2-21#%!*#1!/#1/1!*;213<+)2#!.&.!2.,(1201!&4!*#!3%2/P%#!*#!
$%#112&.!3&))#!-(!ffC=!
!
1 B)#%23(.!"&--#'#!&0!"(%*2&-&'F!f&4.*(/2&.gU&32#/F!0&%!"(%*2&,(134-(%!B.'2&'%($<F!(.*!>./#%,#./2&.1gU&32#/F!&0!h<&%(323!U4%'#&.1gB)#%23(.!
B11&32(/2&.!0&%!h<&%(323!U4%'#%FgB)#%23(.!i#(%/!B11&32(/2&.gB)#%23(.!U&32#/F!&0!^43-#(%!"(%*2&-&'F
2 B)#%23(.!"&--#'#!&0!"(%*2&-&'F!f&4.*(/2&.gB)#%23(.!i#(%/!B11&32(/2&.g!U&32#/F!0&%!"(%*2&,(134-(%!B.'2&'%($<F!(.*!>./#%,#./2&.1

CCECQA
! 4
LE PROGRAMME!
!
!
Catégories professionnelles
!
N#1!$%&0#112&..#-1!3&.3#%.+1!$(%!3#!$%&'%())#!1&./!D!!
" "(%*2&-&'4#1!(.'2&$-(1/232#.1!#@#%l(./!#.!BA42/(2.#!
"#!$%&'%())#!1?(*%#11#!L!3#1!$%&0#112&..#-1!*#!)(.2P%#!2.*2,2*4#--#=!
!
Mode d’exercice des participants
N#!$%&'%())#!1?(*%#11#!(4@!$%&0#112&..#-1!D!
" N29+%(4@K!
" U(-(%2+1!*#1!+/(9-211#)#./1!*#!1(./+=!
!
Orientations nationales et/ou régionales
N#!$%&'%())#!67"K!%+$&.*!(4@!&%2#./(/2&.1!.(/2&.(-#1!#/g&4!%+'2&.(-#1!142,(./#1!D!!
E m%2#./(/2&.!M!D!3&./%294#%!L!-?()+-2&%(/2&.!*#!-(!$%21#!#.!3<(%'#!*#1!$(/2#./1!*(.1!-(!)#14%#!&n!2-!
%+$&.*!(4@!&9:#3/201!142,(./1!D!
# -?&$/2)21(/2&.!*#1!1/%(/+'2#1!*2('.&1/2A4#1!#/!/<+%($#4/2A4#1!*(.1!-#1!$(/<&-&'2#1!(2'4S1!#/!
3<%&.2A4#1!G!
# -(! $%&)&/2&.! *#1! $(%3&4%1! *#! 1(./+! #/! *#! 1&2.1K! 3&)$%#.(./! $&4%! -#! $(/2#./! -#! :41/#!
#.3<(W.#)#./! *#!-?2./#%,#./2&.! *#1! *200+%#./#1! 3&)$+/#.3#1! $%&0#112&..#--#1! -2+#1!
*2%#3/#)#./!&4!2.*2%#3/#)#./!(4@!1&2.1!$%+,#./201!#/!34%(/201!G!
# -(!)(W/%21#!*#1!2.*23(/2&.1!#/!3&./%#E2.*23(/2&.1!*#1!(3/#1!*2('.&1/231!#/!/<+%($#4/2A4#1K!*#1!
$%#13%2$/2&.1! #.!)(/2P%#! *#! )+*23()#./1K! *#! *21$&12/201! )+*23(4@K! *?#@()#.1! 92&-&'2A4#1K!
*#!/%(.1$&%/1!1(.2/(2%#1!G!
# -#1! $%&'%())#1! *?+/4*#1! 3-2.2A4#1! #/! +$2*+)2&-&'2A4#1! ,21(./! L! +,(-4#%! *#1! $%(/2A4#1! #/! L!
(3/4(-21#%!#/g&4!3&)$-+/#%!*#1!%#3&))(.*(/2&.1!*#!9&..#!$%(/2A4#!3-2.2A4#=!
!
!
Méthode
N#!$%&'%())#!67"!#1/!*#!/F$#!)2@/#!5)(:&%2/(2%#)#./!$%+1#./2#-8!#/!3&)92.#!!
E *#4@!/#)$1!*?(.(-F1#!*#1!$%(/2A4#1!$%&0#112&..#--#1!$(%!-?2./#%)+*2(2%#!*;4.#!(.(-F1#!*;2.*23(/#4%1!
*#!$%(/2A4#1!3-2.2A4#=!
ET!
E 4.#! (3/2,2/+! *?(3A4212/2&.! *#1! 3&..(211(.3#1!D! $#%0#3/2&..#)#./! $&4%! -(! $&1#! *#! -;2.*23(/2&.! *#1!
(3/#1!*;(.'2&$-(1/2#!3<#I!-#1!$(/2#./1!1/(9-#1=!
Durée du programme
!
N#!$%&'%())#!67"!#1/!3&.l4!$&4%!4.#!*4%+#!*#!Y!(.1!L!3&)$/#%!*#!-?2.13%2$/2&.=!
!

CCECQA
! 5
Recommandations de l’organisme et prérequis
!
7%+%#A421!D!!
" B3/2,2/+!*;(.'2&$-(1/2#!#.!BA42/(2.#!G!
" C#34#2-!*#1!*&..+#1!*4!%#'21/%#!*#!3(%*2&-&'2#!2./#%,#./2&..#--#!5B">CB8!G!
" Q.'('#)#./!2.*2,2*4#-!*4!$%&0#112&..#-!(4!$%&'%())#!67"!
!
Détail du programme
"#!$%&'%())#!3&)$%#.*!/%&21!+/($#1!
!
Etape$1$
Analyse$ d'indicateurs$ de$ pratiques$ clinique$ recueillis$ par$ le$ registre$ de$
pratiques$$ACIRA$
Etape$2$
Formation$:$ «$ indication$ des$ actes$ d'angioplastie$ coronaire$ chez$ les$ patients$
coronariens$stables$»$
Etape$3$
Suivi$d'activité$:$Mesure$et$évaluation$à$1$an$de$l’évolution$des$pratiques$
1. Evaluation des pratiques professionnelles : Analyse d'indicateurs de
pratiques clinique recueillis par le registre de pratiques ACIRA
\!2.*23(/#4%1!*#!$%(/2A4#!3-2.2A4#!$&4%!-;(.(-F1#!*#!-(!$#%/2.#.3#!
h%&21! 2.*23(/#4%1! *#! $%(/2A4#! 3-2.2A4#! 1&./! 4/2-21+1! (02.! *;(.(-F1#%! -;2.*23(/2&.!*;(.'2&$-(1/2#! 3<#I! -#1!
$(/2#./1!3&%&.(%2#.1!1/(9-#1!D!
E h(4@! *;(3/#1!A42! &./! 9+.+0232+! *#! /#1/1! *;213<+)2#! .&.! 2.,(1201! (,(./! -;(.'2&$-(1/2#!5+$%#4,#!
*;#00&%/K!+3<&3(%*2&'%($<2#!*#!1/%#11K!132./2'%($<2#!)F&3(%*2A4#K!>Co!3(%*2(A4#8!G!
E h(4@! *;(3/#1!A42! &./! 9+.+0232+! *;4.#! )#14%#! *#! -(! %+1#%,#! 3&%&.(2%#! 5ffC8! (4! 3&4%1! *#!
-;(.'2&$-(1/2#!G!
E h(4@!*;(3/#1!A42!&./!9+.+0232+!*#!/#1/1!*;213<+)2#!.&.!2.,(1201!(,(./!-;(.'2&$-(1/2#!&4!*;4.#!)#14%#!
*#!-(!%+1#%,#!3&%&.(2%#!5ffC8!(4!3&4%1!*#!-;(.'2&$-(1/2#=!
7&4%!3<(34.!*#1!2.*23(/#4%1K!4.#!(.(-F1#!#.!1&41E'%&4$#!*#!$(/2#./1!$&-F,(134-(2%#1!L!%21A4#!#1/!%+(-21+#!
5X'#K! *2(9P/#K! /(9('21)#K! (./+3+*#./1K! 0%(3/2&.! *?+:#3/2&.! *4! ,#./%234-#! '(43<#! *2)2.4+#K! $(/2#./!
$-4%2/%&.34-(2%#===8=!
N#1! %+14-/(/1! 1&./! $%+1#./+1! $&4%! 3<(A4#! 3(%*2&-&'4#! $(%/232$(./! (4! $%&'%())#!(,#3! 4.#! 3&)$(%(21&.!
%+'2&.(-#!#./%#!$%&0#112&..#-1=!
!
m%'(.21(/2&.!
N#1!2.*23(/#4%1!*#!$%(/2A4#!3-2.2A4#!1#%&./!(*%#11+1!L!3<(A4#!3(%*2&-&'4#!$(%!-;+A42$#!*4!%#'21/%#!B">CB=!
"#1! %+14-/(/1! *#! $%(/2A4#1! 1#%&./! #.142/#! *2134/+1!-&%1! *;4.! +3<(.'#! 2.*2,2*4#-! #./%#!-#! 6&3/#4%! Q)2-2#!
N#1(2.#K!%#1$&.1(9-#!*4!$%&'%())#K!!#/!-#!$%&0#112&..#-!*#!1(./+=!
N#! 3(%*2&-&'4#! $&4%%(! (2.12! 1#! 12/4#%! $(%! %($$&%/! (4@! %+14-/(/1! %+'2&.(4@!)(21! +'(-#)#./! (4@!
%#3&))(.*(/2&.1=!
!
2. Formation : « indication des actes d'angioplastie coronaire chez les patients
coronariens stables »
!
>-!1?('2/!*?4.#!0&%)(/2&.!*#!$#%0#3/2&..#)#./!$&4%!2*#./202#%!/&4/!*;(9&%*!-#1!/#1/1!*;213<+)2#!.&.!2.,(1201!
L!%+(-21#%!(,(./!/&4/#!(.'2&$-(1/2#!3<#I!-#1!$(/2#./1!3&%&.(%2#.1!1/(9-#1=!6(.1!4.!1#3&.*!/#)$1K!2-!1;('2/!*#!
*+02.2%! -#! 3(%(3/P%#! ($$%&$%2+! &4! .&.! *#! -(! %+(-21(/2&.! *;4.#! (.'2&$-(1/2#! #.! 0&.3/2&.! *4! %21A4#!
*;+,+.#)#./1!3(%*2&E,(134-(2%#1=!
N(!0&%)(/2&.!#1/!$%+1#./2#--#!#/!1#!*+%&4-#!14%!4.#!:&4%.+#=!
!